Literature DB >> 22828281

Inositol polyphosphate 5-phosphatases; new players in the regulation of cilia and ciliopathies.

Sarah E Conduit1, Jennifer M Dyson, Christina A Mitchell.   

Abstract

Phosphoinositides regulate numerous cellular events via the recruitment and activation of multiple lipid-binding effector proteins. The precise temporal and spatial regulation of phosphoinositide signals by the co-ordinated activities of phosphoinositide kinases and phosphatases is essential for homeostasis and development. Mutations in two inositol polyphosphate 5-phosphatases, INPP5E and OCRL, cause the cerebrorenal syndromes of Joubert and Lowe's, respectively. INPP5E and OCRL exhibit overlapping phosphoinositide substrate specificity and subcellular localisation, including an association with the primary cilia. Here, we review recent studies that identify a new role for these enzymes in the regulation of primary cilia function. Joubert syndrome has been extensively linked to primary cilia defects, and Lowe's may represent a new class of 'ciliopathy associated' syndromes.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22828281     DOI: 10.1016/j.febslet.2012.07.037

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  33 in total

1.  INPP5E interacts with AURKA, linking phosphoinositide signaling to primary cilium stability.

Authors:  Olga V Plotnikova; Seongjin Seo; Denny L Cottle; Sarah Conduit; Sandra Hakim; Jennifer M Dyson; Christina A Mitchell; Ian M Smyth
Journal:  J Cell Sci       Date:  2014-11-13       Impact factor: 5.285

Review 2.  Ciliopathies: the trafficking connection.

Authors:  Kayalvizhi Madhivanan; Ruben Claudio Aguilar
Journal:  Traffic       Date:  2014-08-11       Impact factor: 6.215

Review 3.  The structure of phosphoinositide phosphatases: Insights into substrate specificity and catalysis.

Authors:  FoSheng Hsu; Yuxin Mao
Journal:  Biochim Biophys Acta       Date:  2014-09-28

4.  Primary Cilia Signaling Promotes Axonal Tract Development and Is Disrupted in Joubert Syndrome-Related Disorders Models.

Authors:  Jiami Guo; James M Otis; Sarah K Suciu; Christy Catalano; Lei Xing; Sandii Constable; Dagmar Wachten; Stephanie Gupton; Janice Lee; Amelia Lee; Katherine H Blackley; Travis Ptacek; Jeremy M Simon; Stephane Schurmans; Garret D Stuber; Tamara Caspary; E S Anton
Journal:  Dev Cell       Date:  2019-12-16       Impact factor: 12.270

Review 5.  Phosphoinositides in the kidney.

Authors:  Leopoldo Staiano; Maria Antonietta De Matteis
Journal:  J Lipid Res       Date:  2018-10-12       Impact factor: 5.922

Review 6.  Primary cilia and kidney injury: current research status and future perspectives.

Authors:  Shixuan Wang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-31

7.  The ciliary GTPase Arl13b regulates cell migration and cell cycle progression.

Authors:  Michal Pruski; Ann Rajnicek; Zhifu Yang; Hannah Clancy; Yu-Qiang Ding; Colin D McCaig; Bing Lang
Journal:  Cell Adh Migr       Date:  2016-03-10       Impact factor: 3.405

8.  A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.

Authors:  S E Conduit; V Ramaswamy; M Remke; D N Watkins; B J Wainwright; M D Taylor; C A Mitchell; J M Dyson
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

9.  Phosphoinositide 5-phosphatases: How do they affect tumourigenesis?

Authors:  Keiji Miyazawa
Journal:  J Biochem       Date:  2012-09-26       Impact factor: 3.387

10.  Defective ciliogenesis in INPP5E-related Joubert syndrome.

Authors:  Isabel Hardee; Ariane Soldatos; Mariska Davids; Thierry Vilboux; Camilo Toro; Karen L David; Carlos R Ferreira; Michele Nehrebecky; Joseph Snow; Audrey Thurm; Theo Heller; Ellen F Macnamara; Meral Gunay-Aygun; Wadih M Zein; William A Gahl; May Christine V Malicdan
Journal:  Am J Med Genet A       Date:  2017-10-20       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.